Illumina provides tools and services to analyze genetic material with life science and clinical lab applications... Show more
ILMN saw its Momentum Indicator move above the 0 level on October 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ILMN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ILMN just turned positive on October 20, 2025. Looking at past instances where ILMN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
ILMN moved above its 50-day moving average on October 20, 2025 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for ILMN moved above the 200-day moving average on September 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .
ILMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day moving average for ILMN crossed bearishly below the 50-day moving average on September 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ILMN entered a downward trend on October 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ILMN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.734) is normal, around the industry mean (12.970). P/E Ratio (12.527) is within average values for comparable stocks, (141.117). Projected Growth (PEG Ratio) (0.617) is also within normal values, averaging (1.817). ILMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.662) is also within normal values, averaging (9.972).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
a manufacturer of integrated systems for the analysis of genetic variation and function
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, ILMN has been closely correlated with A. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if ILMN jumps, then A could also see price increases.
Ticker / NAME | Correlation To ILMN | 1D Price Change % | ||
---|---|---|---|---|
ILMN | 100% | -0.54% | ||
A - ILMN | 70% Closely correlated | +1.87% | ||
TMO - ILMN | 66% Closely correlated | +2.60% | ||
MTD - ILMN | 65% Loosely correlated | +2.09% | ||
RVTY - ILMN | 64% Loosely correlated | +1.66% | ||
BRKR - ILMN | 60% Loosely correlated | +1.76% | ||
More |